President
Projections Research Inc
Dr Mould obtained her bachelor’s degree in 1984 and her PhD in 1989. She spent 30+ years as a pharmacokineticist in industry where she specialized in population pharmacokinetic / pharmacodynamic modeling. She has conducted population PK/PD analyses of hematopoietic agents, monoclonal antibodies, anti-cancer and anti-viral agents, antipsychotic, cardiovascular, and sedative/hypnotic agents.
Dr Mould is president of Projections Research Inc., a consulting company offering pharmacokinetic and pharmacometric services. She is also the founder of Baysient LLC, a company that develops systems to individualize doses of drugs that are difficult to manage. She has published 110 peer-reviewed articles, 19 book chapters and was a co-editor of one textbook. She has made 134 national and international presentations and presented 6 podium sessions on advanced modeling and simulation approaches.
She is an adjunct professor at the URI, OSU, and the University of Florida, and teaches an annual class on disease progression modeling at the NIH. Dr Mould taught 12 courses (OSU, URI and SUNY Buffalo) on specialized aspects of population pharmacokinetic and dynamic modeling. She is a member of the editorial board for Journal of Pharmacokinetics and Pharmacodynamics, Clinical Pharmacology and Therapeutics, and is on the Scientific Advisory Board for Clinical Pharmacology and Therapeutics Pharmacometrics and Systems Pharmacology. She is a Fellow of the American College of Clinical Pharmacology and a Fellow of the American Association of Pharmaceutical Sciences.
Sunday, September 10, 2023
10:00 AM - 11:30 AM PT
Disclosure(s): No financial relationships to disclose
Sunday, September 10, 2023
10:00 AM - 11:30 AM PT
Disclosure(s): No financial relationships to disclose